Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

259
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
259
Dementia01:30

Dementia

162
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
162
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

663
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
663
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
Clinical Trials01:16

Clinical Trials

7.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.1K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

391
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
391

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of a clinical scale for predicting Aβ-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment.

Journal of the neurological sciences·2026
Same author

Selective molecular and network architecture features underlie brain cortical atrophy in dementia with Lewy bodies.

Journal of biomedical science·2026
Same author

"We feel like we don't matter": the work experience of caring for long-term care residents with suspected trauma-related responsive behaviors.

BMC health services research·2026
Same author

Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer's disease.

Neurodegenerative disease management·2026
Same author

Same Patients, Different Health Care Systems-Revisited. Geriatric Care Models in the U.S., Canada, and Europe.

Journal of the American Geriatrics Society·2026
Same author

Examining the effects of alcohol use on verbal memory processes in older adults with mild cognitive impairment.

Journal of Alzheimer's disease : JAD·2026
Same journal

γ-radiation reduces phosphorylated-tau in rhesus macaque brains: potential implications for Alzheimer's disease and other tauopathies.

Alzheimer's research & therapy·2026
Same journal

The potential of key Alzheimer's plasma biomarkers to mimic tau PET MUBADA-based disease staging.

Alzheimer's research & therapy·2026
Same journal

Smoking cessation duration and risk of Alzheimer's disease: a nationwide cohort study in Korea.

Alzheimer's research & therapy·2026
Same journal

Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA).

Alzheimer's research & therapy·2026
Same journal

Structural and molecular determinants of medial temporal lobe network vulnerability in aging and Alzheimer's disease.

Alzheimer's research & therapy·2026
Same journal

Facial phenotypes in Alzheimer's disease: from neurobiology to artificial intelligence.

Alzheimer's research & therapy·2026
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.4K

Multidomain trials to prevent dementia: addressing methodological challenges.

Manuel Montero-Odasso1,2,3, G Y Zou4, Nellie Kamkar5

  • 1Schulich School of Medicine and Dentistry, Department of Medicine and Division of Geriatric Medicine, The University of Western Ontario, London, ON, Canada. mmontero@uwo.ca.

Alzheimer'S Research & Therapy
|July 12, 2022
PubMed
Summary
This summary is machine-generated.

Multidomain lifestyle interventions show promise for dementia prevention. Standardly tailored trial designs offer a pragmatic approach to evaluate these complex interventions and their impact on cognitive health.

Keywords:
Combined interventionsDementiaMultidomain trialsMultifactorial interventions

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

32.7K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K

Related Experiment Videos

Last Updated: Sep 5, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.4K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

32.7K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K

Area of Science:

  • Gerontology
  • Neuroscience
  • Public Health

Background:

  • Multidomain lifestyle interventions targeting multiple dementia risk factors show promise.
  • Designing trials to evaluate individual and combined intervention efficacy presents methodological challenges.
  • Determining intervention efficacy is crucial for individuals, healthcare payers, and resource allocation.

Purpose of the Study:

  • To elaborate on methodological challenges in evaluating multidomain dementia prevention trials.
  • To compare standardly tailored designs with fully factorial designs.
  • To propose analytical strategies to bolster causal inferences in dementia risk reduction studies.

Main Methods:

  • Utilizing a standardly tailored design with two arms: one with tailored multidomain interventions and another with active controls.
  • Comparing the standardly tailored approach with fully factorial designs, discussing advantages and disadvantages.
  • Employing sensitivity and exploratory analyses, including risk reduction scores, to assess the impact of risk factor modification.

Main Results:

  • Standardly tailored designs provide pragmatic and feasible evaluations of multidomain dementia prevention interventions.
  • Challenges exist in post hoc quantification of specific intervention components responsible for cognitive improvements.
  • Risk reduction scores can measure changes in risk factor number or severity within study arms.

Conclusions:

  • Standardly tailored designs are practical for evaluating multidomain dementia risk reduction interventions.
  • Sensitivity and exploratory analyses of risk factor reduction can strengthen causal inferences between intervention and cognitive outcomes.
  • This methodology supports understanding the impact of modifying multiple risk factors on cognitive health.